# NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/rfa-rm-27-002-nih-directors-new-innovator-award-dp2-clinical-trial/  
Official notice: https://www.grants.gov/search-results-detail/360987

> National Institutes of Health offered grants of up to $475,000 (at least $475,000) to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expected to make about 30 awards worth $23.0 million in total. Applications closed on August 17, 2026.

| Field | Value |
|---|---|
| Opportunity number | RFA-RM-27-002 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | August 17, 2026 |
| Award ceiling | $475,000 |
| Award floor | $475,000 |
| Expected awards | 30 |
| Total funding | $23.0 million |
| Cost sharing | not required |
| Assistance Listings | 93.310 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

## What the grant funds

The NIH Director"s New Innovator Award supports early-stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are welcome; topics may involve basic, translational, or clinical research. The NIH Director's New Innovator Award complements other ongoing efforts by NIH and its Institutes and Centers to fund early-stage investigators. The NIH Director"s New Innovator Award is a component of the High-Risk, High-Reward Research (HRHR) program of the NIH Common Fund.

## Questions people ask

### Is RFA-RM-27-002 still open?

No. It closed on August 17, 2026. A newer notice is forecast: RFA-RM-28-002, expected deadline August 19, 2027.

### Who can apply for NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)?

Closed August 17, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $475,000 each. About $23.0 million in total across about 30 awards.

### Who has won Trans-NIH Research Support grants before?

The largest recipients over five fiscal years were Duke University, The Leland Stanford Junior University, University of Pittsburgh - of the Commonwealth System of Higher Education. The program made 4,433 awards worth $5.9 billion in that time.